{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:06:25Z","timestamp":1791216385296,"version":"4.1.0"},"reference-count":50,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1652,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1111\/j.1365-2990.2010.01106.x","type":"journal-article","created":{"date-parts":[[2010,7,6]],"date-time":"2010-07-06T19:40:58Z","timestamp":1278445258000},"page":"243-256","source":"Crossref","is-referenced-by-count":42,"title":["Evaluation of potential synergistic action of a combined treatment with alpha-methyl-prednisolone and taurine on the mdx mouse model of Duchenne muscular dystrophy"],"prefix":"10.1111","volume":"37","author":[{"given":"A.","family":"Cozzoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-F.","family":"Rolland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. F.","family":"Capogrosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. T.","family":"Sblendorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Simonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Nico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,2,22]]},"reference":[{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0165-6147(00)01770-3","article-title":"Molecular pathophysiology and targeted therapeutics for muscular dystrophy","volume":"22","author":"Hoffman","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2008.03.008","article-title":"Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy","volume":"31","author":"Grounds","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1050-1738(00)00075-X","article-title":"How calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes","volume":"10","author":"Alderton","year":"2000","journal-title":"Trends Cardiovasc Med"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1083\/jcb.200203091","article-title":"Involvement of TRPC in the abnormal calcium influx observed in dystrophic (mdx) mouse skeletal muscle fibers","volume":"158","author":"Vandebrouck","year":"2002","journal-title":"J Cell Biol"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1083\/jcb.200301101","article-title":"A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor-regulated channel","volume":"161","author":"Iwata","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.nbd.2004.06.002","article-title":"The alteration of calcium homeostasis in adult dystrophic mdx muscle fibers is worsened by a chronic exercise in vivo","volume":"17","author":"Fraysse","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.nbd.2006.08.010","article-title":"Overactivity of exercise-sensitive cation channels and their impaired modulation by IGF-1 in mdx native muscle fibers: beneficial effect of pentoxifylline","volume":"24","author":"Rolland","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1124\/jpet.102.041343","article-title":"Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1","volume":"304","author":"De Luca","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1042\/BJ20051265","article-title":"BCL-2 overexpression prevents calcium overload and subsequent apoptosis in dystrophic myotubes","volume":"395","author":"Basset","year":"2006","journal-title":"Biochem J"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.nmd.2006.01.013","article-title":"First evaluation of the potential effectiveness in muscular dystrophy of a novel chimeric compound, BN 82270, acting as calpain-inhibitor and anti-oxidant","volume":"16","author":"Burdi","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1113\/jphysiol.2007.132191","article-title":"In situ measurements of calpain activity in isolated muscle fibres from normal and dystrophin-lacking mdx mice","volume":"582","author":"Gailly","year":"2007","journal-title":"J Physiol"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1212\/01.wnl.0000173836.09176.c4","article-title":"Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy","volume":"65","author":"Chen","year":"2005","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1096\/fj.03-1024com","article-title":"Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis","volume":"18","author":"Grounds","year":"2004","journal-title":"FASEB J"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2353\/ajpath.2006.050673","article-title":"Lipid peroxidation inhibition blunts nuclear factor-kappaB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice","volume":"168","author":"Messina","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2990.2007.00798.x","article-title":"Role of tumour necrosis factor alpha, but not of cyclo-oxygenase-2-derived eicosanoids, on functional and morphological indices of dystrophic progression in mdx mice: a pharmacological approach","volume":"33","author":"Pierno","year":"2007","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/hmg\/ddn376","article-title":"Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy","volume":"18","author":"Villalta","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/humu.20918","article-title":"Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations","volume":"30","author":"Aartsma-Rus","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.molmed.2007.10.003","article-title":"New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials","volume":"13","author":"Cossu","year":"2007","journal-title":"Trends Mol Med"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1017\/S1462399409001100","article-title":"Emerging strategies for cell and gene therapy of the muscular dystrophies","volume":"11","author":"Muir","year":"2009","journal-title":"Expert Rev Mol Med"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1096\/fj.04-1859fje","article-title":"Glucocorticoid treatment alleviates dystrophic myofiber pathology by activation of the calcineurin\/NF-AT pathway","volume":"18","author":"St-Pierre","year":"2004","journal-title":"FASEB J"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"e2309","DOI":"10.1371\/journal.pone.0002309","article-title":"IRES-mediated translation of utrophin A is enhanced by glucocorticoid treatment in skeletal muscle cells","volume":"3","author":"Miura","year":"2008","journal-title":"PloS ONE"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.nmd.2007.11.011","article-title":"Microarray analysis of mdx mice expressing high levels of utrophin: therapeutic implications for dystrophin deficiency","volume":"18","author":"Baban","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/eurjhf\/hfp028","article-title":"Contrasting effects of steroids and angiotensin-converting-enzyme inhibitors in a mouse model of dystrophin-deficient cardiomyopathy","volume":"11","author":"Bauer","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1096\/fj.09-134411","article-title":"Automated drug screening with contractile muscle tissue engineered from dystrophic myoblasts","volume":"23","author":"Vandenburgh","year":"2009","journal-title":"FASEB J"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1096\/fj.05-4821fje","article-title":"Persistent and improved functional gain in mdx dystrophic mice after treatment with L-arginine and deflazacort","volume":"20","author":"Archer","year":"2006","journal-title":"FASEB J"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1023\/B:NERE.0000010442.89826.9c","article-title":"Taurine and skeletal muscle disorders","volume":"29","author":"Conte Camerino","year":"2004","journal-title":"Neurochem Res"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.yrtph.2008.01.004","article-title":"Risk assessment for the amino acids taurine, L-glutamine and L-arginine","volume":"50","author":"Shao","year":"2008","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1099-1492(199802)11:1<1::AID-NBM493>3.0.CO;2-D","article-title":"Nuclear magnetic resonance spectroscopy study of muscle growth, mdx dystrophy and glucocorticoid treatments: correlation with repair","volume":"11","author":"McIntosh","year":"1998","journal-title":"NMR Biomed"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/sj.bjp.0703907","article-title":"Alteration of excitation-contraction coupling mechanism in extensor digitorum longus muscle fibres of dystrophic mdx mouse and potential efficacy of taurine","volume":"132","author":"De Luca","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1021\/pr800070p","article-title":"A combined metabolomic and proteomic investigation of the effects of a failure to express dystrophin in the mouse heart","volume":"7","author":"Gulston","year":"2008","journal-title":"J Proteome Res"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0378-1097(03)00611-6","article-title":"Taurine: new implications for an old amino acid","volume":"226","author":"Schuller-Levis","year":"2003","journal-title":"FEMS Microbiol Lett"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.nmd.2009.05.003","article-title":"Developing standard procedures for murine and canine efficacy studies of DMD therapeutics: report of two expert workshops on \u2018Pre-clinical testing for Duchenne dystrophy\u2019: Washington DC, October 27th-28th 2007 and Z\u00fcrich, June 30th-July 1st 2008","volume":"19","author":"Nagaraju","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0002-9440(10)62270-5","article-title":"A multidisciplinary evaluation of the effectiveness of cyclosporine a in dystrophic mdx mice","volume":"166","author":"De Luca","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1152\/japplphysiol.90985.2008","article-title":"Multiple pathological events in exercised dystrophic mdx mice are targeted by pentoxifylline: outcome of a large array of in vivo and ex vivo tests","volume":"106","author":"Burdi","year":"2009","journal-title":"J Appl Physiol"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.nbd.2008.07.009","article-title":"Gentamicin treatment in exercised mdx mice: identification of dystrophin-sensitive pathways and evaluation of efficacy in work-loaded dystrophic muscle","volume":"32","author":"De Luca","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.nmd.2006.07.024","article-title":"Streptomycin reduces stretch-induced membrane permeability in muscles from mdx mice","volume":"16","author":"Whitehead","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1016\/j.febslet.2009.10.033","article-title":"Essential role of TRPV2 ion channel in the sensitivity of dystrophic muscle to eccentric contractions","volume":"583","author":"Zanou","year":"2009","journal-title":"FEBS Lett"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1471-4159.1986.tb02844.x","article-title":"Regulation of taurine transport in rat skeletal muscle","volume":"47","author":"Iwata","year":"1986","journal-title":"J Neurochem"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.yjmcc.2008.03.001","article-title":"Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy","volume":"44","author":"Ito","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1152\/physrev.1992.72.1.101","article-title":"Physiological actions of taurine","volume":"72","author":"Huxtable","year":"1992","journal-title":"Physiol Rev"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1113\/jphysiol.2009.172148","article-title":"Checking your SOCCs and feet: the molecular mechanisms of Ca2+ entry in skeletal muscle","volume":"587","author":"Dirksen","year":"2009","journal-title":"J Physiol"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1113\/jphysiol.2001.012872","article-title":"Effect of taurine on sarcoplasmic reticulum function and force in skinned fast-twitch skeletal muscle fibres of the rat","volume":"538","author":"Bakker","year":"2002","journal-title":"J Physiol"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0014-2999(95)00702-4","article-title":"Effect of taurine depletion on excitation-contraction coupling and Cl- conductance of rat skeletal muscle","volume":"296","author":"De Luca","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0022-3565(24)37710-9","article-title":"Chronic administration of taurine to aged rats improves the electrical and contractile properties of skeletal muscle fibers","volume":"286","author":"Pierno","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s007260200017","article-title":"The cytoprotective role of taurine in exercise-induced muscle injury","volume":"22","author":"Dawson","year":"2002","journal-title":"Amino Acids"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00726-006-0291-4","article-title":"The effect of taurine depletion on the contractile properties and fatigue in fast-twitch skeletal muscle of the mouse","volume":"31","author":"Hamilton","year":"2006","journal-title":"Amino Acids"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1211\/jpp.57.10.0010","article-title":"Protective effect of taurine on myocardial antioxidant status in isoprenaline-induced myocardial infarction in rats","volume":"57","author":"Shiny","year":"2005","journal-title":"J Pharm Pharmacol"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0009-9236(98)90066-2","article-title":"Plasma concentrations and effects of oral methylprednisolone are considerably increased by itraconazole","volume":"64","author":"Varis","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1248\/bpb.26.510","article-title":"Induction of CYP3As in HepG2 cells by several drugs. Association between induction of CYP3A4 and expression of glucocorticoid receptor","volume":"26","author":"Usui","year":"2003","journal-title":"Biol Pharm Bull"},{"key":"10.1111\/j.1365-2990.2010.01106.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0167-4889(02)00345-2","article-title":"Taurine modulates induction of cytochrome P450 3A4 mRNA by rifampicin in the HepG2 cell line","volume":"1593","author":"Matsuda","year":"2002","journal-title":"Biochim Biophys Acta"}],"container-title":["Neuropathology and Applied Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2990.2010.01106.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2990.2010.01106.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T18:26:58Z","timestamp":1740248818000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2990.2010.01106.x"}},"subtitle":["Prednisolone and taurine combination in mdx mice"],"short-title":[],"issued":{"date-parts":[[2011,2,22]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2990.2010.01106.x","relation":{},"ISSN":["0305-1846"],"issn-type":[{"value":"0305-1846","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2,22]]}}}